Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Celula logo — Enhancing reproductive health with innovative, cost-effectiv...

Celula

Enhancing reproductive health with innovative, cost-effective IVD solutions for accurate patient detection and inspector convenience.

Founded 2013 Series B Total: $53.00M Biotechnology, Life Sciences +2

General Information

Company Name Celula
Founded Year 2013
Industries Biotechnology, Life Sciences, Manufacturing +1
Funding Stage Series B
Social

Get notified when Celula moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Celula

Celula is a healthcare company established in 2013, specializing in in-vitro diagnostics (IVD) products. The company's slogan "Enhancing reproductive health with innovative, cost-effective IVD solutions for accurate patient detection and inspector convenience" reflects its focus on reproductive health and commitment to offering integrated and budget-friendly IVD solutions. By aligning with clinical requirements, Celula provides precise diagnostic solutions to patients and equips professionals with user-friendly, advanced products. Having received a CNY50.00M Series B investment on 01 September 2020 from Hanne Capital, Celula has demonstrated its attractiveness to investors, showcasing potential for growth and development within the Biotechnology, Life Sciences, Manufacturing, and Medical Devices industries. The investment further strengthens Celula's position within the market, supporting its mission to enhance reproductive health through innovation and accessibility in IVD solutions.

Taxonomy: reproductive health, in-vitro diagnostics, IVD products, clinical requirements, diagnostic solutions, health products, health diagnostics

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 1
Investor
01 Sep 2020
Angel Round •••••• 3
Investor Investor Investor
09 Oct 2018

Celula Alternatives & Competitors

Celula vs
Wi Inc.- Medical Device Development
Wi Inc.- Medical Device Development United States

Now part of the TE Connectivity´s IVD Solutions Team https://www.linkedin.com/showcase/te-connectivi...

11 employees
Health Care, Medical Devices
Celula vs
nico innovagroup S.r.l.
nico innovagroup S.r.l. Italy

Tomorrow's innovation today: healthcare & biotech solutions

3 employees
Celula vs
Italian Center for Research on Microbiota and Microbiology
Italian Center for Research on Microbiota and Microbiology

Advancing Personalized Microbiome Insights Through Individualized Testing

Biotechnology

FAQ About Celula

Enhancing reproductive health with innovative, cost-effective IVD solutions for accurate patient detection and inspector convenience.
Celula was founded in 2013.
Celula operates in the following industries: Biotechnology, Life Sciences, Manufacturing, Medical Devices.
Celula has completed 2 funding rounds, raising a total of $53.00M. The latest funding stage is Series B.
Top alternatives and competitors to Celula include Wi Inc.- Medical Device Development , nico innovagroup S.r.l., Italian Center for Research on Microbiota and Microbiology, Hzymes Biotech, Bio Lab Diagnostics I Private Limited. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Celula and Wi Inc.- Medical Device Development are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Celula and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy